CD4 and tuberculosis: Second, the benefits of CD4 testing in this analysis arise through increased use of LF‐LAM for TB diagnosis and improved identification of sub‐clinical CM and cryptococcal antigenemia; we do not account for other clinical benefits of CD4 testing and the lack of LF‐LAM use in routine clinical settings.